| pubmed-article:12737488 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12737488 | lifeskim:mentions | umls-concept:C0441635 | lld:lifeskim |
| pubmed-article:12737488 | lifeskim:mentions | umls-concept:C0150141 | lld:lifeskim |
| pubmed-article:12737488 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:12737488 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:12737488 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12737488 | pubmed:dateCreated | 2003-5-9 | lld:pubmed |
| pubmed-article:12737488 | pubmed:abstractText | The optimisation of the formulation of a commercial bubble bath was performed by chemometric analysis of Panel Tests results. A first Panel Test was performed to choose the best essence, among four proposed to the consumers; the best essence chosen was used in the revised commercial bubble bath. Afterwards, the effect of changing the amount of four components (the amount of primary surfactant, the essence, the hydratant and the colouring agent) of the bubble bath was studied by a fractional factorial design. The segmentation of the bubble bath market was performed by a second Panel Test, in which the consumers were requested to evaluate the samples coming from the experimental design. The results were then treated by Principal Component Analysis. The market had two segments: people preferring a product with a rich formulation and people preferring a poor product. The final target, i.e. the optimisation of the formulation for each segment, was obtained by the calculation of regression models relating the subjective evaluations given by the Panel and the compositions of the samples. The regression models allowed to identify the best formulations for the two segments ofthe market. | lld:pubmed |
| pubmed-article:12737488 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12737488 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12737488 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12737488 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12737488 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12737488 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12737488 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12737488 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:12737488 | pubmed:issn | 0003-4592 | lld:pubmed |
| pubmed-article:12737488 | pubmed:author | pubmed-author:MarengoEmilio... | lld:pubmed |
| pubmed-article:12737488 | pubmed:author | pubmed-author:GennaroMaria... | lld:pubmed |
| pubmed-article:12737488 | pubmed:author | pubmed-author:RobottiElisaE | lld:pubmed |
| pubmed-article:12737488 | pubmed:author | pubmed-author:BertettoMarie... | lld:pubmed |
| pubmed-article:12737488 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12737488 | pubmed:volume | 93 | lld:pubmed |
| pubmed-article:12737488 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12737488 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12737488 | pubmed:pagination | 257-68 | lld:pubmed |
| pubmed-article:12737488 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:meshHeading | pubmed-meshheading:12737488... | lld:pubmed |
| pubmed-article:12737488 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12737488 | pubmed:articleTitle | Optimisation of the formulation of a bubble bath by a chemometric approach market segmentation and optimisation. | lld:pubmed |
| pubmed-article:12737488 | pubmed:affiliation | Dipartimento di Scienze e Tecnologie Avanzate, Università del Piemonte Orientale "A. Avogadro", Corso Borsalino 54, 15100 Alessandria, Italy. marengoe@tin.it | lld:pubmed |
| pubmed-article:12737488 | pubmed:publicationType | Journal Article | lld:pubmed |
